U.S. federal trademark · Serial No. 79275036 · Reg. No. 6072032
Medical analysis services for the prediction of response to cancer treatment and its associated clinical outcomes and for the identification of new drug targets for cancer treatment; medical analysis services for the prediction of response to cancer treatment based on computational analysis of host proteins; medical analysis services for discovering new targets to overcome cancer treatment resistance based on computational analysis of host proteins
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.